Combination medication helps patients with type 2 diabetes maintain blood sugar goals

(Brigham and Women's Hospital) Through a randomized, multicenter clinical trial, investigators studied blood glucose results for patients assigned to either take insulin (insulin glargine, IGlar U100) or insulin degludec plus liraglutide (IDegLira), a combination of both insulin and an additional medication to help with blood sugar control. The global study team found that participants who received IDegLira were better able to achieve blood glucose goals and remain at that goal longer compared t...